OK
Orville G Kolterman
SVP, Chief Medical Officer

Orville G Kolterman insider trades: Amylin Pharmaceuticals (AMLN) stock sales

SVP, Chief Medical Officer, Amylin Pharmaceuticals Last trade Mar 1, 2012 69 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
52
Open-market trades
since 2005
1
Company
last trade 2012

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Orville reports to the SEC

Open-market buys and sales

52 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 1, 2012AMLN↓ Sell$32K
Feb 23, 2012AMLN↓ Sell$96K
Feb 8, 2012AMLN↓ Sell$94K
Oct 3, 2011AMLN↓ Sell$131K
Mar 1, 2011AMLN↓ Sell$207K
Feb 1, 2011AMLN↓ Sell$40K
Jan 18, 2011AMLN↓ Sell$38K
Jan 15, 2008AMLN↓ Sell$213K
Jan 2, 2008AMLN↓ Sell$249K
Dec 17, 2007AMLN↓ Sell$192K
Dec 3, 2007AMLN↓ Sell$253K
Nov 15, 2007AMLN↓ Sell$208K
Nov 1, 2007AMLN↓ Sell$295K
Oct 16, 2007AMLN↓ Sell$238K
Oct 1, 2007AMLN↓ Sell$333K
Sep 26, 2007AMLN↓ Sell$250K
Sep 17, 2007AMLN↓ Sell$244K
Sep 4, 2007AMLN↓ Sell$328K
Aug 15, 2007AMLN↓ Sell$491K
Aug 7, 2007AMLN↓ Sell$250K
Aug 1, 2007AMLN↓ Sell$79K
Jul 16, 2007AMLN↓ Sell$292K
Jul 2, 2007AMLN↓ Sell$206K
Jun 15, 2007AMLN↓ Sell$288K
Jun 1, 2007AMLN↓ Sell$231K
May 15, 2007AMLN↓ Sell$283K
May 1, 2007AMLN↓ Sell$206K
Apr 16, 2007AMLN↓ Sell$472K
Mar 15, 2007AMLN↓ Sell$256K
Feb 15, 2007AMLN↓ Sell$269K
Feb 1, 2007AMLN↓ Sell$193K
Jan 16, 2007AMLN↓ Sell$208K
Jan 11, 2007AMLN↓ Sell$200K
Dec 1, 2006AMLN↓ Sell$200K
Nov 1, 2006AMLN↓ Sell$220K
Oct 2, 2006AMLN↓ Sell$218K
Sep 1, 2006AMLN↓ Sell$231K
Aug 7, 2006AMLN↓ Sell$235K
May 1, 2006AMLN↓ Sell$434K
Apr 3, 2006AMLN↓ Sell$485K
Mar 1, 2006AMLN↓ Sell$434K
Feb 1, 2006AMLN↓ Sell$420K
Jan 3, 2006AMLN↓ Sell$343K
Dec 20, 2005AMLN↓ Sell$120K
Dec 1, 2005AMLN↓ Sell$260K
Nov 3, 2005AMLN↓ Sell$70K
Nov 1, 2005AMLN↓ Sell$259K
Oct 3, 2005AMLN↓ Sell$249K
Sep 30, 2005AMLN↓ Sell$70K
Sep 1, 2005AMLN↓ Sell$164K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Orville G Kolterman's insider trades

Orville G Kolterman is SVP, Chief Medical Officer at Amylin Pharmaceuticals (AMLN). Since Aug 23, 2005, Orville has reported no open-market purchases and 52 sales worth $11.9M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (53 filings), grants and awards (16 filings), shares withheld for taxes (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AMLN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.